Robert Andrew Douglas - 16 Nov 2022 Form 4 Insider Report for RESMED INC (RMD)

Signature
Robert Douglas, President and Chief Operating Officer, ResMed Inc.
Issuer symbol
RMD
Transactions as of
16 Nov 2022
Transactions value $
$7,107,732
Form type
4
Filing time
18 Nov 2022, 19:08:03
Previous filing
16 Nov 2022
Next filing
23 Nov 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RMD ResMed Common Stock 40.2K 16 Nov 2022 Direct
holding RMD ResMed Common Stock 228K 16 Nov 2022 Douglas Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Award $7.11M +31.6K $224.58 31.6K 16 Nov 2022 ResMed Common Stock 31.6K $224.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2023, 2024 and 2025.